Abstract

BackgroundChemokine CXCL8 is an important neutrophil chemoattractant implicated in various neurodegenerative disorders. Cytokine/chemokine imbalance, with an increase in proinflammatory cytokines like interleukin-1β and tumor necrosis factor-α within the central nervous system, is a hallmark of human immunodeficiency virus (HIV)-1 infection. We previously reported that HIV-1 infection is linked to upregulation of CXCL8 in brain tissues and human astrocytes. Chemokines play crucial roles in trafficking of leukocytes and trafficking of HIV-1-infected across the blood-brain barrier play an important role in HIV-1 central nervous system disease. In the post-antiretroviral therapy era, low level of productive replication of HIV-1 in brain is a critical component of neuropathogenesis regulation. The present study investigated the effect of CXCL8 on productive infection of HIV-1 in human monocytes-derived macrophages (MDM) and primary human microglia.ResultsHuman MDM and microglia were infected with the blood or brain derived HIV-1 isolates, HIV-1ADA or HIV-1JRFL. Treatment with CXCL8 significantly upregulated HIV-1p24 levels in supernatants of both HIV-1-infected MDM as well as microglia. In addition, the formation of 2-long terminal repeat (LTR) circles, a measure of viral genome integration, was significantly higher in CXCL8-treated, HIV-1-infected MDM and microglia. Transient transfection of U937 cells with HIV-1 LTR luciferase reporter construct resulted in increased promoter activity when treated with CXCL8. Moreover, increased nuclear translocation of nuclear factor-κB was seen in HIV-1-infected MDM following CXCL8 treatment. Blocking CXCL8 receptors CXCR1 and CXCR2 abrogated the CXCL8-mediated enhanced HIV-1 replication.ConclusionOur results show that CXCL8 mediates productive infection of HIV-1 in MDM and microglia via receptors CXCR1 and CXCR2. These results demonstrate that CXCL8 exerts its downstream effects by increasing translocation of nuclear factor-κB into the nucleus, thereby promoting HIV-1 LTR activity.

Highlights

  • Human immunodeficiency virus (HIV)-1 infects CD4+ T cells and monocytes in peripheral blood, which differentiate into tissue specific macrophages

  • Chemokine CXCL8 increases human immunodeficiency virus (HIV)-1p24 levels in monocytes-derived macrophages (MDM) Secretion of viral antigen HIV-1p24 is an important indicator of viral protein production by infected cells

  • We examined HIV-1p24 levels in MDM infected with macrophage tropic blood-derived isolate HIV-1ADA and brain-derived isolate HIV-1JRFL

Read more

Summary

Introduction

Human immunodeficiency virus (HIV)-1 infects CD4+ T cells and monocytes in peripheral blood, which differentiate into tissue specific macrophages. Majority of viral replication in CNS occurs in perivascular macrophages and/or microglia within brain parenchyma [8,9,10]. Low plasma levels of HIV1 are maintained by anti-retroviral therapy, intracellular reservoir of virus persists. Immune activation markers such as interleukin (IL)-6 and sCD14 determine the level of viral replication in HIV-1 infected population [13]. Cytokine/chemokine imbalance, with an increase in proinflammatory cytokines like interleukin-1b and tumor necrosis factor-a within the central nervous system, is a hallmark of human immunodeficiency virus (HIV)-1 infection. The present study investigated the effect of CXCL8 on productive infection of HIV-1 in human monocytes-derived macrophages (MDM) and primary human microglia

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call